Home » Topics » BioWorld Science

BioWorld Science
RSS

Sichuan Haisco Pharmaceutical describes new JAK inhibitors

Oct. 8, 2021

Merck KGaA and Ryvu Therapeutics divulge new ACSS2 inhibitors

Oct. 8, 2021

MCT4 is a prognostic marker in anaplastic thyroid cancer

Oct. 8, 2021

Evotec presents ISR pathway modulators

Oct. 8, 2021

Minghui Pharmaceutical scientists synthesize new JAK inhibitors

Oct. 8, 2021

AstraZeneca patents SLC12A5 activators

Oct. 8, 2021

Chronic myeloid leukemia therapy may be enhanced by ULK1 inhibition

Oct. 7, 2021

Amgen and Neumora collaborate in neuropsychiatric and neurodegenerative diseases

Oct. 7, 2021

RAC1 predicts dabrafenib resistance in papillary thyroid cancer

Oct. 7, 2021

Thymosin beta4 reverses cognitive impairment in mouse model of AD

Oct. 7, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...